avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Elf1
|
ENSMUSG00000036461.9 | E74-like factor 1 |
Elf2
|
ENSMUSG00000037174.12 | E74-like factor 2 |
Etv2
|
ENSMUSG00000006311.8 | ets variant 2 |
Elf4
|
ENSMUSG00000031103.6 | E74-like factor 4 (ets domain transcription factor) |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Elf4 | mm10_v2_chrX_-_48454152_48454193 | 0.49 | 2.4e-03 | Click! |
Elf2 | mm10_v2_chr3_-_51340555_51340584 | 0.29 | 8.3e-02 | Click! |
Elf1 | mm10_v2_chr14_+_79515618_79515694 | 0.12 | 4.9e-01 | Click! |
Etv2 | mm10_v2_chr7_-_30635852_30635852 | 0.12 | 5.0e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_-_118620763 | 19.44 |
ENSMUST00000071972.4
|
Wdr65
|
WD repeat domain 65 |
chr11_+_87793722 | 12.29 |
ENSMUST00000143021.2
|
Mpo
|
myeloperoxidase |
chr2_-_26021532 | 12.26 |
ENSMUST00000136750.1
|
Ubac1
|
ubiquitin associated domain containing 1 |
chr8_+_72761868 | 11.77 |
ENSMUST00000058099.8
|
F2rl3
|
coagulation factor II (thrombin) receptor-like 3 |
chr16_-_18811972 | 11.40 |
ENSMUST00000000028.7
ENSMUST00000115585.1 |
Cdc45
|
cell division cycle 45 |
chr11_+_87793470 | 11.35 |
ENSMUST00000020779.4
|
Mpo
|
myeloperoxidase |
chr2_-_26021679 | 10.89 |
ENSMUST00000036509.7
|
Ubac1
|
ubiquitin associated domain containing 1 |
chr7_-_24760311 | 10.34 |
ENSMUST00000063956.5
|
Cd177
|
CD177 antigen |
chr10_+_79879614 | 10.06 |
ENSMUST00000006679.8
|
Prtn3
|
proteinase 3 |
chr8_-_85380964 | 9.98 |
ENSMUST00000122452.1
|
Mylk3
|
myosin light chain kinase 3 |
chr9_-_57836706 | 9.38 |
ENSMUST00000164010.1
ENSMUST00000171444.1 ENSMUST00000098686.3 |
Arid3b
|
AT rich interactive domain 3B (BRIGHT-like) |
chr8_+_22974844 | 9.37 |
ENSMUST00000110688.2
ENSMUST00000121802.2 |
Ank1
|
ankyrin 1, erythroid |
chr1_+_40515362 | 9.16 |
ENSMUST00000027237.5
|
Il18rap
|
interleukin 18 receptor accessory protein |
chr8_+_23139064 | 8.85 |
ENSMUST00000033947.8
|
Ank1
|
ankyrin 1, erythroid |
chr6_-_125191535 | 8.80 |
ENSMUST00000043848.4
|
Ncapd2
|
non-SMC condensin I complex, subunit D2 |
chr7_-_127042420 | 8.78 |
ENSMUST00000032915.6
|
Kif22
|
kinesin family member 22 |
chr1_-_132390301 | 8.66 |
ENSMUST00000132435.1
|
Tmcc2
|
transmembrane and coiled-coil domains 2 |
chr8_+_23139030 | 8.57 |
ENSMUST00000121075.1
|
Ank1
|
ankyrin 1, erythroid |
chr14_-_76556662 | 8.29 |
ENSMUST00000064517.7
|
Serp2
|
stress-associated endoplasmic reticulum protein family member 2 |
chr2_+_91650116 | 7.54 |
ENSMUST00000111331.2
|
Arhgap1
|
Rho GTPase activating protein 1 |
chrX_+_100625737 | 7.53 |
ENSMUST00000048962.3
|
Kif4
|
kinesin family member 4 |
chr8_+_3665747 | 7.45 |
ENSMUST00000014118.2
|
1810033B17Rik
|
RIKEN cDNA 1810033B17 gene |
chr11_-_94653964 | 7.42 |
ENSMUST00000039949.4
|
Eme1
|
essential meiotic endonuclease 1 homolog 1 (S. pombe) |
chr14_-_70627008 | 7.38 |
ENSMUST00000110984.2
|
Dmtn
|
dematin actin binding protein |
chr3_-_89418287 | 7.37 |
ENSMUST00000029679.3
|
Cks1b
|
CDC28 protein kinase 1b |
chr6_-_40585783 | 7.35 |
ENSMUST00000177178.1
ENSMUST00000129948.2 ENSMUST00000101491.4 |
Clec5a
|
C-type lectin domain family 5, member a |
chr8_-_71723308 | 7.34 |
ENSMUST00000125092.1
|
Fcho1
|
FCH domain only 1 |
chr19_-_9899450 | 7.28 |
ENSMUST00000025562.7
|
Incenp
|
inner centromere protein |
chr6_-_115758974 | 7.23 |
ENSMUST00000072933.6
|
Tmem40
|
transmembrane protein 40 |
chr4_-_119189949 | 7.21 |
ENSMUST00000124626.1
|
Ermap
|
erythroblast membrane-associated protein |
chr19_+_6084983 | 6.97 |
ENSMUST00000025704.2
|
Cdca5
|
cell division cycle associated 5 |
chr16_+_48994185 | 6.86 |
ENSMUST00000117994.1
ENSMUST00000048374.5 |
C330027C09Rik
|
RIKEN cDNA C330027C09 gene |
chr3_-_129969989 | 6.82 |
ENSMUST00000146340.1
|
Ccdc109b
|
coiled-coil domain containing 109B |
chr2_+_109280738 | 6.80 |
ENSMUST00000028527.7
|
Kif18a
|
kinesin family member 18A |
chr3_+_28781305 | 6.75 |
ENSMUST00000060500.7
|
Eif5a2
|
eukaryotic translation initiation factor 5A2 |
chr18_+_61953048 | 6.74 |
ENSMUST00000051720.5
|
Sh3tc2
|
SH3 domain and tetratricopeptide repeats 2 |
chr1_-_173333503 | 6.65 |
ENSMUST00000038227.4
|
Darc
|
Duffy blood group, chemokine receptor |
chr10_-_75940633 | 6.46 |
ENSMUST00000059658.4
|
Gm867
|
predicted gene 867 |
chr2_+_5845243 | 6.40 |
ENSMUST00000127116.1
|
Nudt5
|
nudix (nucleoside diphosphate linked moiety X)-type motif 5 |
chr6_-_70792155 | 6.39 |
ENSMUST00000066134.5
|
Rpia
|
ribose 5-phosphate isomerase A |
chr3_+_103832562 | 6.29 |
ENSMUST00000062945.5
|
Bcl2l15
|
BCLl2-like 15 |
chr2_-_156839790 | 6.27 |
ENSMUST00000134838.1
ENSMUST00000137463.1 ENSMUST00000149275.2 |
Gm14230
|
predicted gene 14230 |
chr9_-_123968683 | 6.25 |
ENSMUST00000026911.4
|
Ccr1
|
chemokine (C-C motif) receptor 1 |
chr2_-_170406501 | 6.19 |
ENSMUST00000154650.1
|
Bcas1
|
breast carcinoma amplified sequence 1 |
chr8_+_83955507 | 6.16 |
ENSMUST00000005607.8
|
Asf1b
|
ASF1 anti-silencing function 1 homolog B (S. cerevisiae) |
chr1_+_91541074 | 6.14 |
ENSMUST00000086843.4
|
Asb1
|
ankyrin repeat and SOCS box-containing 1 |
chr7_+_24370255 | 6.08 |
ENSMUST00000171904.1
|
Kcnn4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
chr11_-_72550255 | 5.96 |
ENSMUST00000021154.6
|
Spns3
|
spinster homolog 3 |
chr18_+_60774675 | 5.95 |
ENSMUST00000118551.1
|
Rps14
|
ribosomal protein S14 |
chr3_-_90695706 | 5.89 |
ENSMUST00000069960.5
ENSMUST00000117167.1 |
S100a9
|
S100 calcium binding protein A9 (calgranulin B) |
chr10_-_88146867 | 5.87 |
ENSMUST00000164121.1
ENSMUST00000164803.1 ENSMUST00000168163.1 ENSMUST00000048518.9 |
Parpbp
|
PARP1 binding protein |
chr19_-_7019423 | 5.85 |
ENSMUST00000040772.8
|
Fermt3
|
fermitin family homolog 3 (Drosophila) |
chr5_+_90772435 | 5.82 |
ENSMUST00000031320.6
|
Pf4
|
platelet factor 4 |
chr2_+_91650169 | 5.81 |
ENSMUST00000090614.4
|
Arhgap1
|
Rho GTPase activating protein 1 |
chr3_-_129970152 | 5.71 |
ENSMUST00000029624.8
|
Ccdc109b
|
coiled-coil domain containing 109B |
chr6_+_113531675 | 5.67 |
ENSMUST00000036340.5
ENSMUST00000101051.2 |
Fancd2
|
Fanconi anemia, complementation group D2 |
chr2_+_164805082 | 5.65 |
ENSMUST00000052107.4
|
Zswim3
|
zinc finger SWIM-type containing 3 |
chr4_-_119190005 | 5.64 |
ENSMUST00000138395.1
ENSMUST00000156746.1 |
Ermap
|
erythroblast membrane-associated protein |
chr10_-_117792663 | 5.62 |
ENSMUST00000167943.1
ENSMUST00000064848.5 |
Nup107
|
nucleoporin 107 |
chr5_+_33658567 | 5.58 |
ENSMUST00000114426.3
|
Tacc3
|
transforming, acidic coiled-coil containing protein 3 |
chr3_-_14778452 | 5.56 |
ENSMUST00000094365.4
|
Car1
|
carbonic anhydrase 1 |
chr19_-_10203880 | 5.48 |
ENSMUST00000142241.1
ENSMUST00000116542.2 ENSMUST00000025651.5 ENSMUST00000156291.1 |
Fen1
|
flap structure specific endonuclease 1 |
chr18_+_60774510 | 5.43 |
ENSMUST00000025511.3
|
Rps14
|
ribosomal protein S14 |
chr2_+_25423234 | 5.43 |
ENSMUST00000134259.1
ENSMUST00000100320.4 |
Fut7
|
fucosyltransferase 7 |
chr17_+_31208049 | 5.42 |
ENSMUST00000173776.1
|
Ubash3a
|
ubiquitin associated and SH3 domain containing, A |
chr17_-_33890584 | 5.37 |
ENSMUST00000114361.2
ENSMUST00000173492.1 |
Kifc1
|
kinesin family member C1 |
chr15_+_85859689 | 5.37 |
ENSMUST00000170629.1
|
Gtse1
|
G two S phase expressed protein 1 |
chr11_+_101316200 | 5.37 |
ENSMUST00000142640.1
ENSMUST00000019470.7 |
Psme3
|
proteaseome (prosome, macropain) activator subunit 3 (PA28 gamma, Ki) |
chr9_+_56089962 | 5.32 |
ENSMUST00000059206.7
|
Pstpip1
|
proline-serine-threonine phosphatase-interacting protein 1 |
chr12_-_78906929 | 5.31 |
ENSMUST00000021544.7
|
Plek2
|
pleckstrin 2 |
chr16_+_36277145 | 5.29 |
ENSMUST00000042097.9
|
Stfa1
|
stefin A1 |
chr1_+_135132693 | 5.28 |
ENSMUST00000049449.4
|
Ptpn7
|
protein tyrosine phosphatase, non-receptor type 7 |
chr9_-_70421533 | 5.27 |
ENSMUST00000034742.6
|
Ccnb2
|
cyclin B2 |
chr2_+_5845017 | 5.24 |
ENSMUST00000026927.3
ENSMUST00000179748.1 |
Nudt5
|
nudix (nucleoside diphosphate linked moiety X)-type motif 5 |
chr11_+_72961163 | 5.24 |
ENSMUST00000108486.1
ENSMUST00000108484.1 ENSMUST00000021142.7 ENSMUST00000108485.2 ENSMUST00000163326.1 |
Atp2a3
|
ATPase, Ca++ transporting, ubiquitous |
chr17_-_33890539 | 5.20 |
ENSMUST00000173386.1
|
Kifc1
|
kinesin family member C1 |
chr14_-_70635946 | 5.19 |
ENSMUST00000022695.9
|
Dmtn
|
dematin actin binding protein |
chrX_-_7978027 | 5.17 |
ENSMUST00000125418.1
|
Gata1
|
GATA binding protein 1 |
chr4_-_152448808 | 5.13 |
ENSMUST00000159840.1
ENSMUST00000105648.2 |
Kcnab2
|
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
chr17_+_34605855 | 5.11 |
ENSMUST00000037489.8
|
Agpat1
|
1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha) |
chr7_-_126369543 | 5.10 |
ENSMUST00000032997.6
|
Lat
|
linker for activation of T cells |
chr5_-_107726017 | 5.08 |
ENSMUST00000159263.2
|
Gfi1
|
growth factor independent 1 |
chr13_-_100775844 | 5.02 |
ENSMUST00000075550.3
|
Cenph
|
centromere protein H |
chr17_-_57194170 | 4.95 |
ENSMUST00000005976.6
|
Tnfsf14
|
tumor necrosis factor (ligand) superfamily, member 14 |
chr7_+_5062143 | 4.94 |
ENSMUST00000005041.7
|
U2af2
|
U2 small nuclear ribonucleoprotein auxiliary factor (U2AF) 2 |
chr12_+_109747903 | 4.93 |
ENSMUST00000183084.1
ENSMUST00000182300.1 |
Mirg
|
miRNA containing gene |
chr2_+_152847993 | 4.90 |
ENSMUST00000028969.8
|
Tpx2
|
TPX2, microtubule-associated protein homolog (Xenopus laevis) |
chr7_-_122132844 | 4.89 |
ENSMUST00000106469.1
ENSMUST00000063587.6 ENSMUST00000106468.1 ENSMUST00000130149.1 ENSMUST00000098068.3 |
Palb2
|
partner and localizer of BRCA2 |
chr17_-_29264115 | 4.88 |
ENSMUST00000024802.8
|
Ppil1
|
peptidylprolyl isomerase (cyclophilin)-like 1 |
chr4_-_141078302 | 4.87 |
ENSMUST00000030760.8
|
Necap2
|
NECAP endocytosis associated 2 |
chr19_-_10577362 | 4.86 |
ENSMUST00000025568.2
|
Tmem138
|
transmembrane protein 138 |
chr1_-_132367879 | 4.85 |
ENSMUST00000142609.1
|
Tmcc2
|
transmembrane and coiled-coil domains 2 |
chr4_-_46404224 | 4.85 |
ENSMUST00000107764.2
|
Hemgn
|
hemogen |
chr2_+_152847961 | 4.85 |
ENSMUST00000164120.1
ENSMUST00000178997.1 ENSMUST00000109816.1 |
Tpx2
|
TPX2, microtubule-associated protein homolog (Xenopus laevis) |
chr19_+_18713225 | 4.79 |
ENSMUST00000055792.7
|
D030056L22Rik
|
RIKEN cDNA D030056L22 gene |
chr4_-_41314877 | 4.79 |
ENSMUST00000030145.8
|
Dcaf12
|
DDB1 and CUL4 associated factor 12 |
chr7_-_99238564 | 4.78 |
ENSMUST00000064231.7
|
Mogat2
|
monoacylglycerol O-acyltransferase 2 |
chr11_-_12037391 | 4.76 |
ENSMUST00000093321.5
|
Grb10
|
growth factor receptor bound protein 10 |
chr5_+_33658550 | 4.73 |
ENSMUST00000152847.1
|
Tacc3
|
transforming, acidic coiled-coil containing protein 3 |
chr3_+_153844209 | 4.72 |
ENSMUST00000044089.3
|
Asb17
|
ankyrin repeat and SOCS box-containing 17 |
chr7_+_110768169 | 4.72 |
ENSMUST00000170374.1
|
Ampd3
|
adenosine monophosphate deaminase 3 |
chr4_-_119320417 | 4.69 |
ENSMUST00000147077.1
ENSMUST00000056458.7 ENSMUST00000106321.2 ENSMUST00000106319.1 ENSMUST00000106317.1 ENSMUST00000106318.1 |
Ppih
|
peptidyl prolyl isomerase H |
chr8_-_18950932 | 4.69 |
ENSMUST00000055503.5
ENSMUST00000095438.3 |
Xkr5
|
X Kell blood group precursor-related family, member 5 |
chr7_-_127137807 | 4.63 |
ENSMUST00000049931.5
|
Spn
|
sialophorin |
chr4_-_45320580 | 4.63 |
ENSMUST00000030003.3
|
Exosc3
|
exosome component 3 |
chr6_+_86371489 | 4.62 |
ENSMUST00000089558.5
|
Snrpg
|
small nuclear ribonucleoprotein polypeptide G |
chr11_-_102469839 | 4.61 |
ENSMUST00000103086.3
|
Itga2b
|
integrin alpha 2b |
chr4_-_136053343 | 4.55 |
ENSMUST00000102536.4
|
Rpl11
|
ribosomal protein L11 |
chr17_+_26917091 | 4.53 |
ENSMUST00000078961.4
|
Kifc5b
|
kinesin family member C5B |
chr9_+_111019284 | 4.53 |
ENSMUST00000035077.3
|
Ltf
|
lactotransferrin |
chr16_-_22161450 | 4.52 |
ENSMUST00000115379.1
|
Igf2bp2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr10_-_78244602 | 4.52 |
ENSMUST00000000384.6
|
Trappc10
|
trafficking protein particle complex 10 |
chr2_-_163645125 | 4.51 |
ENSMUST00000017851.3
|
Serinc3
|
serine incorporator 3 |
chr9_+_27030159 | 4.49 |
ENSMUST00000073127.7
ENSMUST00000086198.4 |
Ncapd3
|
non-SMC condensin II complex, subunit D3 |
chr7_+_143005046 | 4.49 |
ENSMUST00000009396.6
|
Tspan32
|
tetraspanin 32 |
chr15_-_55090422 | 4.47 |
ENSMUST00000110231.1
ENSMUST00000023059.6 |
Dscc1
|
defective in sister chromatid cohesion 1 homolog (S. cerevisiae) |
chr4_-_118437331 | 4.47 |
ENSMUST00000006565.6
|
Cdc20
|
cell division cycle 20 |
chr3_+_90669063 | 4.45 |
ENSMUST00000069927.8
|
S100a8
|
S100 calcium binding protein A8 (calgranulin A) |
chr7_-_142661858 | 4.43 |
ENSMUST00000145896.2
|
Igf2
|
insulin-like growth factor 2 |
chr7_-_132813528 | 4.43 |
ENSMUST00000097999.2
|
Fam53b
|
family with sequence similarity 53, member B |
chr17_+_35241746 | 4.42 |
ENSMUST00000068056.5
ENSMUST00000174757.1 |
Ddx39b
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B |
chr19_-_5726240 | 4.42 |
ENSMUST00000049295.8
ENSMUST00000075606.4 |
Ehbp1l1
|
EH domain binding protein 1-like 1 |
chr2_-_181691771 | 4.40 |
ENSMUST00000108778.1
ENSMUST00000165416.1 |
Rgs19
|
regulator of G-protein signaling 19 |
chr15_+_79895017 | 4.40 |
ENSMUST00000023054.7
|
Apobec3
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 3 |
chr7_+_12922290 | 4.40 |
ENSMUST00000108539.1
ENSMUST00000004554.7 ENSMUST00000147435.1 ENSMUST00000137329.1 |
Rps5
|
ribosomal protein S5 |
chr10_-_30655859 | 4.39 |
ENSMUST00000092610.4
|
Ncoa7
|
nuclear receptor coactivator 7 |
chr2_+_156840077 | 4.36 |
ENSMUST00000081335.6
ENSMUST00000073352.3 |
Tgif2
|
TGFB-induced factor homeobox 2 |
chr17_+_47593516 | 4.35 |
ENSMUST00000182874.1
|
Ccnd3
|
cyclin D3 |
chr1_+_135799402 | 4.34 |
ENSMUST00000152208.1
ENSMUST00000152075.1 ENSMUST00000154463.1 ENSMUST00000139986.1 |
Tnni1
|
troponin I, skeletal, slow 1 |
chrX_+_48695004 | 4.34 |
ENSMUST00000033433.2
|
Rbmx2
|
RNA binding motif protein, X-linked 2 |
chr5_-_137072254 | 4.33 |
ENSMUST00000077523.3
ENSMUST00000041388.4 |
Serpine1
|
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
chr2_-_170427828 | 4.32 |
ENSMUST00000013667.2
ENSMUST00000109152.2 ENSMUST00000068137.4 |
Bcas1
|
breast carcinoma amplified sequence 1 |
chr7_-_141443989 | 4.32 |
ENSMUST00000026580.5
|
Lrdd
|
leucine-rich and death domain containing |
chr4_-_63403330 | 4.32 |
ENSMUST00000035724.4
|
Akna
|
AT-hook transcription factor |
chr11_+_69914179 | 4.32 |
ENSMUST00000057884.5
|
Gps2
|
G protein pathway suppressor 2 |
chr8_+_94179089 | 4.32 |
ENSMUST00000034215.6
|
Mt1
|
metallothionein 1 |
chr3_+_84666192 | 4.31 |
ENSMUST00000107682.1
|
Tmem154
|
transmembrane protein 154 |
chr19_-_7341792 | 4.30 |
ENSMUST00000164205.1
ENSMUST00000165286.1 ENSMUST00000168324.1 ENSMUST00000032557.8 |
Mark2
|
MAP/microtubule affinity-regulating kinase 2 |
chr1_-_88205674 | 4.28 |
ENSMUST00000119972.2
|
Dnajb3
|
DnaJ (Hsp40) homolog, subfamily B, member 3 |
chr1_+_63176818 | 4.28 |
ENSMUST00000129339.1
|
Eef1b2
|
eukaryotic translation elongation factor 1 beta 2 |
chr7_-_133709051 | 4.25 |
ENSMUST00000124759.1
ENSMUST00000106144.1 |
Uros
|
uroporphyrinogen III synthase |
chr11_-_102897123 | 4.22 |
ENSMUST00000067444.3
|
Gfap
|
glial fibrillary acidic protein |
chr7_+_109519139 | 4.21 |
ENSMUST00000143107.1
|
Rpl27a
|
ribosomal protein L27A |
chr17_-_24527925 | 4.20 |
ENSMUST00000176652.1
|
Traf7
|
TNF receptor-associated factor 7 |
chr19_+_18713192 | 4.20 |
ENSMUST00000062753.2
|
D030056L22Rik
|
RIKEN cDNA D030056L22 gene |
chr4_+_108579445 | 4.18 |
ENSMUST00000102744.3
|
Orc1
|
origin recognition complex, subunit 1 |
chr7_-_4752972 | 4.17 |
ENSMUST00000183971.1
ENSMUST00000182173.1 ENSMUST00000182738.1 ENSMUST00000184143.1 ENSMUST00000182111.1 ENSMUST00000182048.1 ENSMUST00000063324.7 |
Cox6b2
|
cytochrome c oxidase subunit VIb polypeptide 2 |
chr2_+_118814195 | 4.15 |
ENSMUST00000110842.1
|
Knstrn
|
kinetochore-localized astrin/SPAG5 binding |
chr4_-_116123618 | 4.12 |
ENSMUST00000102704.3
ENSMUST00000102705.3 |
Rad54l
|
RAD54 like (S. cerevisiae) |
chr2_-_164356507 | 4.11 |
ENSMUST00000109367.3
|
Slpi
|
secretory leukocyte peptidase inhibitor |
chr17_-_36867187 | 4.09 |
ENSMUST00000025329.6
ENSMUST00000174195.1 |
Trim15
|
tripartite motif-containing 15 |
chrX_-_7964166 | 4.09 |
ENSMUST00000128449.1
|
Gata1
|
GATA binding protein 1 |
chr5_+_33658123 | 4.08 |
ENSMUST00000074849.6
ENSMUST00000079534.4 |
Tacc3
|
transforming, acidic coiled-coil containing protein 3 |
chr12_-_87444017 | 4.08 |
ENSMUST00000091090.4
|
2700073G19Rik
|
RIKEN cDNA 2700073G19 gene |
chr8_+_84701430 | 4.08 |
ENSMUST00000037165.4
|
Lyl1
|
lymphoblastomic leukemia 1 |
chr17_+_35241838 | 4.07 |
ENSMUST00000173731.1
|
Ddx39b
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B |
chr11_+_70639118 | 4.07 |
ENSMUST00000055184.6
ENSMUST00000108551.2 |
Gp1ba
|
glycoprotein 1b, alpha polypeptide |
chr3_-_15332285 | 4.07 |
ENSMUST00000108361.1
|
Gm9733
|
predicted gene 9733 |
chr2_-_126499839 | 4.06 |
ENSMUST00000040128.5
|
Atp8b4
|
ATPase, class I, type 8B, member 4 |
chr2_+_118814237 | 4.04 |
ENSMUST00000028803.7
ENSMUST00000126045.1 |
Knstrn
|
kinetochore-localized astrin/SPAG5 binding |
chr14_-_37110087 | 4.03 |
ENSMUST00000179488.1
|
2610528A11Rik
|
RIKEN cDNA 2610528A11 gene |
chr6_-_39420418 | 4.01 |
ENSMUST00000031985.6
|
Mkrn1
|
makorin, ring finger protein, 1 |
chr1_+_171767123 | 3.98 |
ENSMUST00000015460.4
|
Slamf1
|
signaling lymphocytic activation molecule family member 1 |
chr12_+_109459843 | 3.96 |
ENSMUST00000173812.1
|
Dlk1
|
delta-like 1 homolog (Drosophila) |
chr13_-_19619820 | 3.95 |
ENSMUST00000002885.6
|
Epdr1
|
ependymin related protein 1 (zebrafish) |
chr11_+_61684419 | 3.94 |
ENSMUST00000093019.5
|
Fam83g
|
family with sequence similarity 83, member G |
chr2_-_164356067 | 3.93 |
ENSMUST00000165980.1
|
Slpi
|
secretory leukocyte peptidase inhibitor |
chr12_-_32208609 | 3.91 |
ENSMUST00000053215.7
|
Pik3cg
|
phosphoinositide-3-kinase, catalytic, gamma polypeptide |
chr4_-_118457450 | 3.91 |
ENSMUST00000106375.1
ENSMUST00000006556.3 ENSMUST00000168404.1 |
Mpl
|
myeloproliferative leukemia virus oncogene |
chr16_-_18811615 | 3.90 |
ENSMUST00000096990.3
|
Cdc45
|
cell division cycle 45 |
chr4_+_126556935 | 3.89 |
ENSMUST00000048391.8
|
Clspn
|
claspin |
chr14_+_46760526 | 3.87 |
ENSMUST00000067426.4
|
Cdkn3
|
cyclin-dependent kinase inhibitor 3 |
chr17_+_48359891 | 3.86 |
ENSMUST00000024792.6
|
Treml1
|
triggering receptor expressed on myeloid cells-like 1 |
chr4_-_118457509 | 3.86 |
ENSMUST00000102671.3
|
Mpl
|
myeloproliferative leukemia virus oncogene |
chr11_-_96977660 | 3.84 |
ENSMUST00000107626.1
ENSMUST00000107624.1 |
Sp2
|
Sp2 transcription factor |
chr4_+_44300876 | 3.83 |
ENSMUST00000045607.5
|
Melk
|
maternal embryonic leucine zipper kinase |
chr14_-_57826128 | 3.83 |
ENSMUST00000022536.2
|
Ska3
|
spindle and kinetochore associated complex subunit 3 |
chr4_+_136172367 | 3.82 |
ENSMUST00000061721.5
|
E2f2
|
E2F transcription factor 2 |
chr2_+_84840612 | 3.81 |
ENSMUST00000111625.1
|
Slc43a1
|
solute carrier family 43, member 1 |
chr1_+_91540553 | 3.80 |
ENSMUST00000027538.7
|
Asb1
|
ankyrin repeat and SOCS box-containing 1 |
chr2_+_164940742 | 3.79 |
ENSMUST00000137626.1
|
Mmp9
|
matrix metallopeptidase 9 |
chr17_-_24073479 | 3.79 |
ENSMUST00000017090.5
|
Kctd5
|
potassium channel tetramerisation domain containing 5 |
chr17_-_24527830 | 3.78 |
ENSMUST00000176353.1
ENSMUST00000176237.1 |
Traf7
|
TNF receptor-associated factor 7 |
chr6_+_39420378 | 3.76 |
ENSMUST00000090237.2
|
Gm10244
|
predicted gene 10244 |
chr2_-_164745916 | 3.76 |
ENSMUST00000109328.1
ENSMUST00000043448.1 |
Wfdc3
Wfdc3
|
WAP four-disulfide core domain 3 WAP four-disulfide core domain 3 |
chr9_-_20952838 | 3.76 |
ENSMUST00000004202.9
|
Dnmt1
|
DNA methyltransferase (cytosine-5) 1 |
chr1_+_174172738 | 3.74 |
ENSMUST00000027817.7
|
Spta1
|
spectrin alpha, erythrocytic 1 |
chr7_-_132813799 | 3.73 |
ENSMUST00000097998.2
|
Fam53b
|
family with sequence similarity 53, member B |
chr2_+_22895482 | 3.72 |
ENSMUST00000053729.7
|
Pdss1
|
prenyl (solanesyl) diphosphate synthase, subunit 1 |
chr11_-_11462408 | 3.71 |
ENSMUST00000020413.3
|
Zpbp
|
zona pellucida binding protein |
chr2_-_23155864 | 3.71 |
ENSMUST00000028119.6
|
Mastl
|
microtubule associated serine/threonine kinase-like |
chr17_+_47593444 | 3.71 |
ENSMUST00000182209.1
|
Ccnd3
|
cyclin D3 |
chr15_-_77643270 | 3.70 |
ENSMUST00000181154.1
ENSMUST00000180949.1 ENSMUST00000181467.1 ENSMUST00000166623.2 |
Apol11b
|
apolipoprotein L 11b |
chr3_-_130730375 | 3.70 |
ENSMUST00000079085.6
|
Rpl34
|
ribosomal protein L34 |
chr2_+_127336152 | 3.70 |
ENSMUST00000028846.6
|
Dusp2
|
dual specificity phosphatase 2 |
chr2_-_172370506 | 3.69 |
ENSMUST00000109139.1
ENSMUST00000028997.7 ENSMUST00000109140.3 |
Aurka
|
aurora kinase A |
chr11_+_116198853 | 3.68 |
ENSMUST00000021130.6
|
Ten1
|
TEN1 telomerase capping complex subunit |
chr16_-_3718105 | 3.68 |
ENSMUST00000023180.7
ENSMUST00000100222.2 |
Mefv
|
Mediterranean fever |
chr3_-_129831374 | 3.66 |
ENSMUST00000029643.8
|
Gar1
|
GAR1 ribonucleoprotein homolog (yeast) |
chr5_+_99979061 | 3.66 |
ENSMUST00000046721.1
|
4930524J08Rik
|
RIKEN cDNA 4930524J08 gene |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.8 | 26.4 | GO:0002148 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
5.4 | 16.2 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
4.6 | 18.4 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
4.2 | 12.6 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
3.5 | 10.6 | GO:0072382 | minus-end-directed vesicle transport along microtubule(GO:0072382) |
3.4 | 10.3 | GO:0070488 | neutrophil aggregation(GO:0070488) |
3.1 | 9.3 | GO:0030221 | basophil differentiation(GO:0030221) |
3.1 | 3.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
3.0 | 18.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
2.8 | 11.3 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
2.6 | 7.7 | GO:0035702 | monocyte homeostasis(GO:0035702) |
2.5 | 14.9 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
2.3 | 9.4 | GO:0046898 | response to cycloheximide(GO:0046898) |
2.3 | 7.0 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
2.2 | 8.9 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
2.0 | 16.0 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
2.0 | 10.0 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
2.0 | 9.9 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
2.0 | 4.0 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
1.9 | 5.8 | GO:0033624 | negative regulation of integrin activation(GO:0033624) |
1.9 | 5.6 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
1.9 | 5.6 | GO:0009826 | unidimensional cell growth(GO:0009826) |
1.8 | 8.8 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
1.7 | 5.2 | GO:1904959 | regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
1.7 | 5.2 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
1.7 | 10.3 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
1.7 | 5.0 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
1.7 | 5.0 | GO:2000872 | positive regulation of progesterone secretion(GO:2000872) |
1.7 | 8.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
1.6 | 6.4 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
1.6 | 7.9 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.5 | 4.6 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
1.5 | 4.6 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) negative regulation of hypersensitivity(GO:0002884) |
1.5 | 4.6 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
1.5 | 13.6 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
1.5 | 14.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
1.5 | 11.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.5 | 33.9 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
1.5 | 4.4 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
1.5 | 4.4 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
1.5 | 8.7 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
1.4 | 7.2 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
1.4 | 8.6 | GO:0032796 | uropod organization(GO:0032796) |
1.4 | 5.7 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
1.4 | 1.4 | GO:0061511 | centriole elongation(GO:0061511) |
1.4 | 4.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
1.4 | 4.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.3 | 1.3 | GO:1904528 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
1.3 | 2.7 | GO:0048254 | snoRNA localization(GO:0048254) |
1.3 | 5.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.3 | 2.6 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
1.3 | 5.0 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
1.3 | 1.3 | GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity(GO:2000277) |
1.2 | 5.0 | GO:0045575 | basophil activation(GO:0045575) |
1.2 | 4.9 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
1.2 | 3.7 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.2 | 3.6 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
1.2 | 10.9 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
1.2 | 7.1 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
1.2 | 4.7 | GO:0006231 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
1.2 | 44.8 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
1.2 | 5.9 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
1.2 | 3.5 | GO:0070476 | rRNA (guanine-N7)-methylation(GO:0070476) |
1.1 | 4.6 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
1.1 | 11.3 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
1.1 | 6.7 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
1.1 | 3.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
1.1 | 4.5 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
1.1 | 7.7 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
1.1 | 5.4 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
1.1 | 14.0 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
1.1 | 1.1 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
1.1 | 5.3 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
1.1 | 9.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
1.1 | 4.3 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
1.1 | 7.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
1.1 | 3.2 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
1.1 | 16.9 | GO:0030953 | astral microtubule organization(GO:0030953) |
1.0 | 3.1 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) positive regulation of cytolysis in other organism(GO:0051714) |
1.0 | 7.2 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
1.0 | 3.0 | GO:1901738 | regulation of vitamin A metabolic process(GO:1901738) |
1.0 | 5.0 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
1.0 | 5.0 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
1.0 | 2.0 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
1.0 | 3.0 | GO:0010751 | regulation of arginine metabolic process(GO:0000821) negative regulation of nitric oxide mediated signal transduction(GO:0010751) negative regulation of cellular amino acid metabolic process(GO:0045763) |
1.0 | 8.9 | GO:0032264 | IMP salvage(GO:0032264) |
1.0 | 1.0 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
1.0 | 5.8 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
0.9 | 2.8 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.9 | 0.9 | GO:2000426 | negative regulation of apoptotic cell clearance(GO:2000426) |
0.9 | 4.7 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.9 | 3.8 | GO:0071226 | cellular response to molecule of fungal origin(GO:0071226) |
0.9 | 3.7 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.9 | 3.7 | GO:0030576 | Cajal body organization(GO:0030576) |
0.9 | 4.6 | GO:1902167 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902167) |
0.9 | 3.6 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.9 | 4.5 | GO:0009597 | detection of virus(GO:0009597) |
0.9 | 0.9 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.9 | 4.5 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.9 | 7.2 | GO:1904378 | maintenance of unfolded protein(GO:0036506) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.9 | 14.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.9 | 0.9 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.9 | 1.8 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
0.9 | 1.8 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.9 | 2.6 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.9 | 4.4 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.9 | 7.9 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.9 | 2.6 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.9 | 0.9 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.9 | 2.6 | GO:0045004 | DNA replication proofreading(GO:0045004) |
0.8 | 11.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.8 | 5.0 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.8 | 0.8 | GO:0048478 | replication fork protection(GO:0048478) |
0.8 | 14.9 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.8 | 2.5 | GO:0036292 | DNA rewinding(GO:0036292) |
0.8 | 9.0 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.8 | 3.3 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.8 | 6.5 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.8 | 0.8 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.8 | 1.6 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.8 | 8.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.8 | 3.2 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.8 | 2.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.8 | 8.8 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.8 | 2.4 | GO:0030862 | positive regulation of polarized epithelial cell differentiation(GO:0030862) |
0.8 | 4.8 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.8 | 6.3 | GO:0061718 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.8 | 2.3 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.8 | 7.8 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.8 | 3.9 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.8 | 0.8 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.8 | 1.5 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.8 | 2.3 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.7 | 2.2 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.7 | 3.7 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.7 | 4.5 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.7 | 2.2 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.7 | 3.7 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.7 | 2.9 | GO:0021941 | negative regulation of cerebellar granule cell precursor proliferation(GO:0021941) |
0.7 | 4.4 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.7 | 2.2 | GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
0.7 | 2.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.7 | 1.4 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.7 | 1.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.7 | 2.8 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.7 | 5.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.7 | 2.8 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.7 | 2.1 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.7 | 19.2 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
0.7 | 5.5 | GO:0015074 | DNA integration(GO:0015074) |
0.7 | 1.4 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
0.7 | 2.7 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.7 | 2.7 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.7 | 3.4 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.7 | 26.4 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.7 | 4.1 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.7 | 3.4 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.7 | 0.7 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.7 | 4.0 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.7 | 3.3 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
0.7 | 0.7 | GO:0007356 | thorax and anterior abdomen determination(GO:0007356) |
0.7 | 1.3 | GO:0090265 | immune complex clearance(GO:0002434) immune complex clearance by monocytes and macrophages(GO:0002436) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) |
0.7 | 5.2 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.6 | 3.9 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.6 | 8.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.6 | 2.6 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.6 | 1.3 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.6 | 4.4 | GO:0070944 | neutrophil mediated killing of bacterium(GO:0070944) |
0.6 | 3.8 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.6 | 0.6 | GO:1903632 | positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
0.6 | 1.3 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.6 | 24.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.6 | 1.9 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.6 | 6.8 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.6 | 7.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.6 | 3.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.6 | 1.8 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
0.6 | 40.0 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.6 | 1.2 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.6 | 4.3 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.6 | 1.8 | GO:1904170 | regulation of bleb assembly(GO:1904170) |
0.6 | 1.8 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
0.6 | 1.8 | GO:0002352 | B cell negative selection(GO:0002352) |
0.6 | 3.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.6 | 4.8 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.6 | 3.0 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.6 | 7.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.6 | 1.8 | GO:0071846 | actin filament debranching(GO:0071846) |
0.6 | 1.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.6 | 2.9 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.6 | 1.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.6 | 0.6 | GO:2000328 | regulation of T-helper 17 cell lineage commitment(GO:2000328) |
0.6 | 7.6 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.6 | 5.9 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.6 | 2.9 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.6 | 5.3 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.6 | 7.5 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.6 | 5.2 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.6 | 1.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.6 | 2.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.6 | 7.4 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.6 | 6.8 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.6 | 6.2 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.6 | 1.7 | GO:0090297 | positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) stress-induced mitochondrial fusion(GO:1990046) |
0.6 | 0.6 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.6 | 2.2 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.6 | 3.3 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.6 | 0.6 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.5 | 2.7 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.5 | 11.5 | GO:0007099 | centriole replication(GO:0007099) |
0.5 | 2.7 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.5 | 1.6 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.5 | 3.2 | GO:0006868 | glutamine transport(GO:0006868) |
0.5 | 5.3 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.5 | 2.1 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
0.5 | 1.1 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.5 | 3.2 | GO:0032202 | telomere assembly(GO:0032202) |
0.5 | 6.9 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.5 | 2.1 | GO:0015786 | UDP-glucose transport(GO:0015786) |
0.5 | 2.6 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.5 | 4.7 | GO:0051014 | actin filament severing(GO:0051014) |
0.5 | 1.5 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.5 | 2.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.5 | 3.5 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.5 | 2.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.5 | 1.5 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.5 | 1.5 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.5 | 1.5 | GO:0040038 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
0.5 | 1.5 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.5 | 2.0 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.5 | 3.0 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.5 | 1.5 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.5 | 12.3 | GO:0051225 | spindle assembly(GO:0051225) |
0.5 | 1.5 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
0.5 | 1.5 | GO:0016132 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
0.5 | 2.0 | GO:0072738 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.5 | 11.7 | GO:0090307 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.5 | 1.5 | GO:2000043 | regulation of cardiac cell fate specification(GO:2000043) |
0.5 | 0.5 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.5 | 3.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.5 | 5.3 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.5 | 20.3 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.5 | 1.0 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
0.5 | 2.8 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.5 | 6.1 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.5 | 2.4 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
0.5 | 0.5 | GO:1902299 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
0.5 | 7.0 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.5 | 2.8 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.5 | 1.8 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.5 | 0.9 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.5 | 4.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.5 | 5.0 | GO:0051382 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.5 | 0.9 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.5 | 2.3 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.5 | 0.9 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) |
0.5 | 1.4 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.4 | 1.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.4 | 2.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.4 | 2.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.4 | 1.8 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
0.4 | 0.9 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.4 | 2.2 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.4 | 1.3 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.4 | 8.7 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.4 | 1.3 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.4 | 1.3 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.4 | 1.7 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.4 | 1.7 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.4 | 2.1 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.4 | 3.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.4 | 4.3 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.4 | 2.1 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.4 | 1.7 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.4 | 0.4 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.4 | 4.2 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.4 | 0.8 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
0.4 | 1.3 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.4 | 11.3 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.4 | 1.3 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
0.4 | 1.7 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.4 | 3.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.4 | 0.8 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
0.4 | 2.5 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.4 | 4.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.4 | 1.2 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.4 | 0.8 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.4 | 0.4 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.4 | 5.2 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.4 | 6.4 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.4 | 0.8 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.4 | 2.8 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.4 | 2.4 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
0.4 | 8.4 | GO:0045730 | respiratory burst(GO:0045730) |
0.4 | 6.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.4 | 0.8 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.4 | 2.8 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.4 | 1.2 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.4 | 5.9 | GO:1904874 | positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.4 | 1.2 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.4 | 0.8 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.4 | 1.6 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.4 | 3.9 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.4 | 7.8 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.4 | 1.9 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.4 | 5.8 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.4 | 1.5 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.4 | 4.6 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.4 | 0.8 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.4 | 0.8 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.4 | 0.4 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.4 | 1.9 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.4 | 1.5 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.4 | 0.4 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.4 | 1.5 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.4 | 5.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.4 | 10.6 | GO:0030539 | male genitalia development(GO:0030539) |
0.4 | 2.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.4 | 3.0 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.4 | 1.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.4 | 2.6 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.4 | 10.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.4 | 13.3 | GO:0006284 | base-excision repair(GO:0006284) |
0.4 | 3.7 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.4 | 1.5 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.4 | 1.1 | GO:0006592 | ornithine biosynthetic process(GO:0006592) |
0.4 | 1.1 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.4 | 1.8 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.4 | 0.4 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.4 | 2.1 | GO:0002432 | granuloma formation(GO:0002432) |
0.4 | 9.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.4 | 12.0 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.4 | 2.5 | GO:0002467 | germinal center formation(GO:0002467) |
0.4 | 8.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.3 | 6.6 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.3 | 5.9 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.3 | 3.1 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.3 | 2.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.3 | 1.4 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
0.3 | 6.5 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.3 | 6.8 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.3 | 2.0 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
0.3 | 0.7 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.3 | 7.7 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.3 | 2.7 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.3 | 0.7 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.3 | 1.7 | GO:0002924 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) abortive mitotic cell cycle(GO:0033277) |
0.3 | 7.3 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.3 | 1.0 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
0.3 | 1.3 | GO:0032218 | riboflavin transport(GO:0032218) |
0.3 | 1.0 | GO:0015811 | L-cystine transport(GO:0015811) |
0.3 | 0.3 | GO:0001743 | optic placode formation(GO:0001743) |
0.3 | 4.9 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.3 | 3.9 | GO:0006968 | cellular defense response(GO:0006968) |
0.3 | 1.9 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.3 | 2.6 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.3 | 0.3 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
0.3 | 1.3 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.3 | 0.6 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
0.3 | 1.9 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.3 | 3.5 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.3 | 0.6 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.3 | 0.9 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.3 | 0.9 | GO:0003127 | detection of nodal flow(GO:0003127) detection of endogenous stimulus(GO:0009726) |
0.3 | 0.9 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.3 | 3.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.3 | 2.8 | GO:0036309 | T-tubule organization(GO:0033292) protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.3 | 1.9 | GO:0007144 | female meiosis I(GO:0007144) |
0.3 | 0.3 | GO:0061193 | taste bud development(GO:0061193) |
0.3 | 7.7 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.3 | 0.9 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.3 | 1.2 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.3 | 1.5 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.3 | 2.8 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.3 | 2.4 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.3 | 1.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.3 | 1.2 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.3 | 0.6 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.3 | 1.5 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.3 | 0.6 | GO:0015675 | nickel cation transport(GO:0015675) |
0.3 | 0.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 2.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.3 | 2.4 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.3 | 0.9 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.3 | 1.2 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.3 | 1.5 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.3 | 3.5 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.3 | 0.9 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
0.3 | 0.6 | GO:1900369 | negative regulation of RNA interference(GO:1900369) |
0.3 | 0.3 | GO:0035700 | astrocyte chemotaxis(GO:0035700) regulation of astrocyte chemotaxis(GO:2000458) |
0.3 | 0.6 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.3 | 1.1 | GO:0060005 | vestibular reflex(GO:0060005) |
0.3 | 0.3 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.3 | 1.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.3 | 0.3 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.3 | 1.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.3 | 0.6 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.3 | 1.7 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.3 | 1.7 | GO:1903182 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.3 | 0.8 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.3 | 2.2 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.3 | 1.9 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.3 | 0.8 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.3 | 1.1 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.3 | 1.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.3 | 0.8 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.3 | 2.4 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.3 | 0.3 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.3 | 2.4 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.3 | 4.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.3 | 0.8 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.3 | 2.1 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.3 | 0.3 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.3 | 0.5 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.3 | 0.5 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.3 | 2.9 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.3 | 7.4 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.3 | 2.9 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.3 | 5.0 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.3 | 4.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 1.6 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.3 | 2.9 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.3 | 0.8 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.3 | 1.0 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.3 | 1.3 | GO:0019516 | lactate oxidation(GO:0019516) |
0.3 | 5.6 | GO:0006301 | postreplication repair(GO:0006301) |
0.3 | 3.3 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.3 | 1.5 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.3 | 1.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.3 | 2.0 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 1.0 | GO:0010458 | exit from mitosis(GO:0010458) |
0.3 | 0.8 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.3 | 2.3 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.3 | 0.8 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.3 | 1.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.3 | 0.8 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.3 | 2.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.3 | 0.5 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.2 | 1.5 | GO:0033028 | myeloid cell apoptotic process(GO:0033028) |
0.2 | 10.2 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.2 | 0.7 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.2 | 0.2 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.2 | 8.0 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.2 | 1.5 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.2 | 2.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 0.7 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 4.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 1.0 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 0.2 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.2 | 0.7 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.2 | 1.9 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.2 | 0.2 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.2 | 1.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.2 | 2.9 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 0.7 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.2 | 4.0 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.2 | 3.3 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.2 | 0.7 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.2 | 0.9 | GO:0070827 | chromatin maintenance(GO:0070827) heterochromatin maintenance(GO:0070829) |
0.2 | 3.1 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 0.5 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.2 | 1.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.2 | 0.5 | GO:0072711 | cellular response to hydroxyurea(GO:0072711) |
0.2 | 3.9 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.2 | 0.9 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.2 | 0.2 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.2 | 0.5 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.2 | 0.7 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.2 | 0.9 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.2 | 1.4 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.2 | 1.6 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.2 | 2.3 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.2 | 0.9 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 1.3 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.2 | 1.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 1.1 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.2 | 0.7 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 0.7 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
0.2 | 0.9 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.2 | 2.7 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.2 | 0.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 1.1 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.2 | 1.5 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.2 | 2.6 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.2 | 4.9 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.2 | 17.3 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.2 | 1.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 1.3 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.4 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.2 | 0.9 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.2 | 0.4 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.2 | 11.0 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 0.8 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.2 | 0.4 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.2 | 1.5 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.2 | 0.8 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.2 | 0.4 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.2 | 0.2 | GO:0003284 | septum primum development(GO:0003284) |
0.2 | 1.5 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.2 | 1.7 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 0.6 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.2 | 0.8 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.2 | 0.4 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 0.6 | GO:1905161 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
0.2 | 0.6 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.2 | 0.6 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 1.0 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.2 | 1.2 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.2 | 0.8 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.2 | 2.8 | GO:0070986 | left/right axis specification(GO:0070986) |
0.2 | 1.6 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.2 | 0.8 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.2 | 0.8 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.2 | 0.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.2 | 6.8 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.2 | 0.6 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.2 | 2.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.2 | 2.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 0.2 | GO:0071104 | response to interleukin-9(GO:0071104) |
0.2 | 0.4 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.2 | 1.7 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 0.6 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.2 | 0.6 | GO:0031283 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
0.2 | 3.4 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 1.1 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 1.9 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.2 | 0.2 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.2 | 0.4 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.2 | 0.9 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
0.2 | 0.4 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.2 | 2.6 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.2 | 1.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.2 | 1.5 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.2 | 0.6 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.2 | 9.9 | GO:0051028 | mRNA transport(GO:0051028) |
0.2 | 0.4 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.2 | 4.4 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 1.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.2 | 0.7 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.2 | 2.0 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.2 | 1.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.2 | 9.9 | GO:0070527 | platelet aggregation(GO:0070527) |
0.2 | 0.5 | GO:0021764 | amygdala development(GO:0021764) |
0.2 | 0.9 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.2 | 1.4 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.2 | 7.0 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.2 | 1.2 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.2 | 0.4 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.2 | 2.6 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.2 | 0.7 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.2 | 0.7 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.2 | 0.2 | GO:1901563 | response to camptothecin(GO:1901563) |
0.2 | 2.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.2 | 0.3 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.2 | 0.5 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
0.2 | 0.2 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.2 | 0.5 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.2 | 5.1 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.2 | 0.3 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.2 | 0.5 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.2 | 0.7 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 1.5 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.2 | 3.9 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 0.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 1.8 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.2 | 1.7 | GO:0035878 | nail development(GO:0035878) |
0.2 | 0.7 | GO:0042891 | antibiotic transport(GO:0042891) |
0.2 | 0.5 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.2 | 30.3 | GO:0000375 | RNA splicing, via transesterification reactions(GO:0000375) |
0.2 | 0.7 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.2 | 0.5 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.2 | 0.7 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.2 | 6.5 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.2 | 0.5 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.2 | 0.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.2 | 0.3 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.2 | 0.5 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 0.3 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.2 | 0.3 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.2 | 0.5 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.2 | 0.5 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.2 | 0.5 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 0.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 0.3 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.2 | 0.6 | GO:0015867 | ATP transport(GO:0015867) |
0.2 | 0.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 1.4 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.2 | 0.2 | GO:0048690 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
0.2 | 0.2 | GO:0072608 | interleukin-10 secretion(GO:0072608) regulation of interleukin-10 secretion(GO:2001179) |
0.2 | 1.5 | GO:0050942 | positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.2 | 0.9 | GO:0098838 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
0.2 | 0.6 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.2 | 0.8 | GO:0060022 | hard palate development(GO:0060022) |
0.2 | 2.1 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.2 | 0.5 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.2 | 1.2 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.4 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 12.3 | GO:0010951 | negative regulation of endopeptidase activity(GO:0010951) |
0.1 | 2.7 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 1.6 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.1 | 1.3 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.1 | 0.1 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.1 | 0.1 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.1 | 0.3 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.1 | 0.7 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.1 | 1.1 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
0.1 | 0.3 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) |
0.1 | 0.6 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.1 | 2.0 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 1.0 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 5.3 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.4 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 1.9 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.7 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 0.3 | GO:0050685 | positive regulation of mRNA processing(GO:0050685) |
0.1 | 0.5 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 1.4 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 1.0 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 0.9 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.1 | 0.8 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.1 | 4.5 | GO:0006414 | translational elongation(GO:0006414) |
0.1 | 0.4 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.1 | 1.3 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.1 | GO:0060983 | epicardium-derived cardiac vascular smooth muscle cell differentiation(GO:0060983) |
0.1 | 0.5 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.1 | 0.7 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) negative regulation of immunoglobulin secretion(GO:0051025) |
0.1 | 0.7 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 0.5 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 0.9 | GO:0051610 | serotonin uptake(GO:0051610) |
0.1 | 0.3 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.1 | 0.9 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 8.3 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.1 | 0.5 | GO:0043137 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 1.1 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.1 | 1.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.5 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.5 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 0.3 | GO:1902896 | terminal web assembly(GO:1902896) |
0.1 | 0.9 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 1.2 | GO:0030220 | platelet formation(GO:0030220) |
0.1 | 0.2 | GO:0009153 | purine deoxyribonucleotide biosynthetic process(GO:0009153) |
0.1 | 0.5 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.1 | 0.2 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.1 | 0.1 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.1 | 0.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.5 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 1.2 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 0.4 | GO:0070295 | renal water absorption(GO:0070295) |
0.1 | 1.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 1.6 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 0.8 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.8 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 1.8 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.1 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.1 | 0.2 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.1 | 0.7 | GO:0015822 | ornithine transport(GO:0015822) |
0.1 | 0.7 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 2.6 | GO:0001706 | endoderm formation(GO:0001706) |
0.1 | 1.0 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.1 | 0.8 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 1.1 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 2.0 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.1 | 5.9 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 0.7 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 1.2 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
0.1 | 0.5 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.4 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.1 | 1.2 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.1 | 7.2 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.5 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.1 | 0.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 0.4 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.1 | 1.9 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.1 | 0.2 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.3 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.5 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.5 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.6 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.2 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.1 | 0.9 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.1 | 1.8 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.1 | 0.2 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 1.9 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.1 | 0.4 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.1 | 0.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 1.8 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) circadian sleep/wake cycle, sleep(GO:0050802) |
0.1 | 0.4 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.4 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.5 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.4 | GO:0032986 | protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.4 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
0.1 | 1.6 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.2 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.4 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 1.3 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 0.2 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 1.2 | GO:0071554 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.1 | 0.2 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.1 | 0.9 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 1.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 3.1 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.3 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.1 | 0.5 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.1 | 0.5 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.5 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.5 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.1 | 0.1 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.1 | 0.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 1.1 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 2.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.2 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 0.3 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.1 | 0.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 1.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 1.6 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.1 | GO:0001805 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.1 | 0.1 | GO:0042335 | cuticle development(GO:0042335) |
0.1 | 0.4 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.2 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 3.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.4 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.1 | 0.3 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.1 | 0.6 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 3.4 | GO:1902041 | regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902041) |
0.1 | 0.1 | GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
0.1 | 6.0 | GO:1903955 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 1.2 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.1 | 1.0 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.3 | GO:1902870 | camera-type eye photoreceptor cell fate commitment(GO:0060220) negative regulation of neural retina development(GO:0061076) negative regulation of retina development in camera-type eye(GO:1902867) negative regulation of amacrine cell differentiation(GO:1902870) |
0.1 | 0.4 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 1.9 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.6 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.1 | 0.4 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 1.8 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.1 | 0.3 | GO:2000698 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
0.1 | 0.1 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.1 | 0.7 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.2 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.1 | 0.1 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
0.1 | 0.8 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.7 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.1 | 0.4 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.1 | 0.3 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.1 | 2.6 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.1 | 0.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 4.0 | GO:0042100 | B cell proliferation(GO:0042100) |
0.1 | 0.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.2 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.1 | 0.5 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 0.2 | GO:2000332 | response to linoleic acid(GO:0070543) blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
0.1 | 0.6 | GO:0055064 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.1 | 2.2 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 0.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 1.7 | GO:0060004 | reflex(GO:0060004) |
0.1 | 1.2 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.1 | 8.6 | GO:1990823 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.1 | 0.5 | GO:1903624 | regulation of DNA catabolic process(GO:1903624) |
0.1 | 0.2 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar Purkinje cell layer maturation(GO:0021691) cerebellar cortex maturation(GO:0021699) |
0.1 | 0.2 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.1 | 2.8 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.5 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.6 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.4 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.1 | 0.8 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.5 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.1 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.1 | 0.1 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 0.1 | GO:0042119 | neutrophil activation(GO:0042119) |
0.1 | 1.3 | GO:0030168 | platelet activation(GO:0030168) |
0.1 | 0.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.4 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.1 | 0.1 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.1 | 1.7 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.1 | 0.1 | GO:0014735 | regulation of muscle atrophy(GO:0014735) |
0.1 | 0.5 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 2.1 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.3 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.8 | GO:1990182 | exosomal secretion(GO:1990182) |
0.1 | 1.6 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.1 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 1.0 | GO:0099612 | protein localization to axon(GO:0099612) |
0.1 | 0.5 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.1 | 4.9 | GO:0031109 | microtubule polymerization or depolymerization(GO:0031109) |
0.1 | 0.2 | GO:0019661 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.1 | 0.7 | GO:0048753 | pigment granule organization(GO:0048753) |
0.1 | 0.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 8.5 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 0.2 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.1 | 0.5 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.1 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.1 | 0.4 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.8 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.3 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.1 | 0.2 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.4 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.1 | 0.4 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.1 | 0.1 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
0.1 | 0.2 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.1 | 0.5 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 1.4 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 0.6 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.1 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.1 | 0.8 | GO:0035306 | positive regulation of dephosphorylation(GO:0035306) |
0.1 | 0.1 | GO:0021506 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
0.1 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
0.1 | 0.2 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 0.2 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.2 | GO:0097435 | fibril organization(GO:0097435) |
0.1 | 2.1 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.1 | GO:0010286 | heat acclimation(GO:0010286) |
0.1 | 3.5 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.1 | 0.2 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.1 | 0.1 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.1 | 0.4 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.6 | GO:1900120 | regulation of receptor binding(GO:1900120) |
0.1 | 0.3 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.1 | 0.2 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 0.3 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.1 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
0.1 | 0.9 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.2 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.2 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.2 | GO:0009223 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.5 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.0 | 0.2 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.4 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.0 | 1.2 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.4 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.2 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.0 | 0.0 | GO:0043039 | tRNA aminoacylation(GO:0043039) |
0.0 | 0.6 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.0 | 0.7 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.1 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.0 | 0.2 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.1 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.0 | 0.0 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.0 | 0.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.2 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.1 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.0 | 1.5 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 0.7 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.0 | 0.1 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.0 | 0.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.0 | 0.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.2 | GO:0046112 | nucleobase biosynthetic process(GO:0046112) |
0.0 | 0.2 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 2.1 | GO:0007338 | single fertilization(GO:0007338) |
0.0 | 0.5 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.2 | GO:0035809 | regulation of urine volume(GO:0035809) |
0.0 | 0.2 | GO:0001510 | RNA methylation(GO:0001510) |
0.0 | 0.1 | GO:0002355 | detection of tumor cell(GO:0002355) |
0.0 | 0.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.6 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.0 | 0.2 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.0 | 0.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.0 | 0.3 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) |
0.0 | 0.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.0 | 0.0 | GO:0032392 | DNA geometric change(GO:0032392) |
0.0 | 0.8 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.0 | 0.2 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.0 | 0.1 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.0 | 1.1 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.2 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.0 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.4 | GO:0070918 | dsRNA fragmentation(GO:0031050) production of miRNAs involved in gene silencing by miRNA(GO:0035196) production of small RNA involved in gene silencing by RNA(GO:0070918) |
0.0 | 0.2 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.0 | 0.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.4 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.0 | 0.4 | GO:0060039 | pericardium development(GO:0060039) |
0.0 | 0.3 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 1.3 | GO:0030802 | regulation of cyclic nucleotide biosynthetic process(GO:0030802) |
0.0 | 0.7 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.0 | 1.4 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.0 | 0.2 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.0 | 0.7 | GO:0030183 | B cell differentiation(GO:0030183) |
0.0 | 0.5 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.0 | 1.0 | GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway(GO:2001237) |
0.0 | 0.4 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.0 | 0.5 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.0 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.2 | GO:0051570 | regulation of histone H3-K9 methylation(GO:0051570) |
0.0 | 0.3 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.2 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.0 | 0.1 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.0 | 0.2 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.0 | 0.1 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.0 | 0.1 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.0 | 0.5 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.0 | 0.3 | GO:0009148 | CTP biosynthetic process(GO:0006241) pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
0.0 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.1 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.0 | 0.2 | GO:0034695 | response to prostaglandin E(GO:0034695) |
0.0 | 0.3 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.0 | 0.1 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
0.0 | 0.1 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.0 | GO:0051057 | positive regulation of small GTPase mediated signal transduction(GO:0051057) |
0.0 | 0.0 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.1 | GO:0015801 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
0.0 | 0.1 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.0 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 0.2 | GO:0001975 | response to amphetamine(GO:0001975) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.0 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.0 | 0.1 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.0 | 0.1 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.0 | 0.2 | GO:0032674 | regulation of interleukin-5 production(GO:0032674) |
0.0 | 0.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 0.7 | GO:0061515 | myeloid cell development(GO:0061515) |
0.0 | 0.0 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.0 | 0.0 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.0 | 0.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.1 | GO:2000323 | negative regulation of transcription by competitive promoter binding(GO:0010944) negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.0 | 0.7 | GO:0006342 | chromatin silencing(GO:0006342) |
0.0 | 0.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.1 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.0 | 0.2 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 0.3 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.0 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.0 | 0.2 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.0 | 0.7 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 0.1 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.0 | 0.4 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.1 | GO:0001502 | cartilage condensation(GO:0001502) |
0.0 | 0.1 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.1 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.0 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.1 | GO:0061309 | neural crest cell migration involved in heart formation(GO:0003147) cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) cell migration involved in heart formation(GO:0060974) cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.0 | 0.0 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.0 | 0.0 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) |
0.0 | 0.3 | GO:0007088 | regulation of mitotic nuclear division(GO:0007088) |
0.0 | 0.0 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.0 | 0.2 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.0 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.1 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.0 | 0.0 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 15.8 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
4.4 | 13.3 | GO:0000799 | nuclear condensin complex(GO:0000799) |
3.1 | 12.6 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
2.2 | 6.7 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
2.2 | 13.3 | GO:0097443 | sorting endosome(GO:0097443) |
2.1 | 8.4 | GO:0097450 | astrocyte end-foot(GO:0097450) |
2.0 | 24.3 | GO:0005687 | U4 snRNP(GO:0005687) |
1.9 | 9.7 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
1.9 | 7.7 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.8 | 3.7 | GO:0042585 | germinal vesicle(GO:0042585) |
1.7 | 7.0 | GO:0008537 | proteasome activator complex(GO:0008537) |
1.7 | 34.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.7 | 27.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
1.7 | 13.3 | GO:0005818 | aster(GO:0005818) |
1.6 | 11.2 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
1.5 | 4.6 | GO:0035101 | FACT complex(GO:0035101) |
1.5 | 13.6 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
1.4 | 12.7 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.3 | 9.4 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.3 | 1.3 | GO:1990423 | RZZ complex(GO:1990423) |
1.3 | 15.5 | GO:0042555 | MCM complex(GO:0042555) |
1.3 | 6.4 | GO:0042583 | chromaffin granule(GO:0042583) |
1.2 | 3.7 | GO:0071920 | cleavage body(GO:0071920) |
1.2 | 6.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.2 | 12.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.1 | 4.5 | GO:0070442 | integrin alphaIIb-beta3 complex(GO:0070442) |
1.1 | 8.8 | GO:0097427 | microtubule bundle(GO:0097427) |
1.1 | 56.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
1.0 | 5.2 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
1.0 | 1.0 | GO:0035061 | interchromatin granule(GO:0035061) |
1.0 | 82.1 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
1.0 | 7.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.0 | 11.8 | GO:0005686 | U2 snRNP(GO:0005686) |
1.0 | 7.9 | GO:0070652 | HAUS complex(GO:0070652) |
1.0 | 18.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
1.0 | 10.5 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
1.0 | 3.8 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.0 | 5.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.9 | 3.8 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.9 | 2.8 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.9 | 8.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.9 | 4.5 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.9 | 4.4 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.9 | 5.3 | GO:0098536 | deuterosome(GO:0098536) |
0.9 | 2.6 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.8 | 7.6 | GO:0008278 | cohesin complex(GO:0008278) |
0.8 | 5.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.8 | 13.4 | GO:0000974 | Prp19 complex(GO:0000974) |
0.8 | 5.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.8 | 5.8 | GO:0000796 | condensin complex(GO:0000796) |
0.8 | 4.9 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.8 | 4.1 | GO:0031523 | Myb complex(GO:0031523) |
0.8 | 20.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.8 | 4.8 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.8 | 2.4 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.8 | 3.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.8 | 3.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.8 | 3.9 | GO:1990745 | EARP complex(GO:1990745) |
0.8 | 5.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.8 | 6.0 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.8 | 12.0 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.7 | 0.7 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.7 | 8.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.7 | 2.9 | GO:0008623 | CHRAC(GO:0008623) |
0.7 | 2.1 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.7 | 4.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.7 | 3.4 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.7 | 1.3 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.7 | 2.6 | GO:0032021 | NELF complex(GO:0032021) |
0.6 | 7.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.6 | 3.8 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.6 | 1.9 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.6 | 6.3 | GO:0000801 | central element(GO:0000801) |
0.6 | 3.7 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.6 | 8.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.6 | 1.8 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
0.6 | 1.8 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.6 | 1.8 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.6 | 3.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.6 | 1.8 | GO:0005940 | septin ring(GO:0005940) |
0.6 | 5.9 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.6 | 5.9 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.6 | 1.8 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.6 | 9.9 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.6 | 2.2 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.5 | 4.9 | GO:0005688 | U6 snRNP(GO:0005688) |
0.5 | 1.6 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.5 | 15.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.5 | 3.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.5 | 1.6 | GO:0000243 | commitment complex(GO:0000243) |
0.5 | 2.7 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.5 | 4.8 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.5 | 3.7 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.5 | 1.6 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.5 | 30.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.5 | 2.5 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
0.5 | 3.0 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) 3M complex(GO:1990393) |
0.5 | 28.9 | GO:0005871 | kinesin complex(GO:0005871) |
0.5 | 3.9 | GO:0042382 | paraspeckles(GO:0042382) |
0.5 | 1.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.5 | 1.4 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
0.5 | 5.3 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.5 | 3.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.5 | 3.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.5 | 6.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.5 | 2.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.5 | 5.9 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.5 | 7.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.5 | 2.3 | GO:0034709 | methylosome(GO:0034709) |
0.4 | 0.9 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.4 | 4.0 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.4 | 0.9 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.4 | 2.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.4 | 3.0 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.4 | 2.1 | GO:1990037 | Lewy body core(GO:1990037) |
0.4 | 16.5 | GO:0005657 | replication fork(GO:0005657) |
0.4 | 1.2 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.4 | 2.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.4 | 4.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.4 | 2.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.4 | 6.7 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.4 | 14.4 | GO:0015030 | Cajal body(GO:0015030) |
0.4 | 14.6 | GO:0002102 | podosome(GO:0002102) |
0.4 | 3.4 | GO:0032009 | early phagosome(GO:0032009) |
0.4 | 3.7 | GO:0045298 | tubulin complex(GO:0045298) |
0.4 | 7.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.4 | 1.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.4 | 2.5 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.4 | 2.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.4 | 6.8 | GO:0032040 | small-subunit processome(GO:0032040) |
0.4 | 4.3 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.4 | 11.1 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.4 | 0.7 | GO:0034657 | GID complex(GO:0034657) |
0.4 | 4.6 | GO:0005876 | spindle microtubule(GO:0005876) |
0.3 | 0.7 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 30.5 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.3 | 0.7 | GO:0032797 | SMN complex(GO:0032797) |
0.3 | 2.7 | GO:0072687 | meiotic spindle(GO:0072687) |
0.3 | 4.1 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.3 | 1.0 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.3 | 2.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 1.3 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
0.3 | 3.3 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.3 | 5.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.3 | 9.8 | GO:0097228 | sperm principal piece(GO:0097228) |
0.3 | 3.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.3 | 21.6 | GO:0072686 | mitotic spindle(GO:0072686) |
0.3 | 1.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.3 | 2.5 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.3 | 0.9 | GO:0031251 | PAN complex(GO:0031251) |
0.3 | 6.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.3 | 1.8 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.3 | 5.4 | GO:0005861 | troponin complex(GO:0005861) |
0.3 | 7.5 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.3 | 0.9 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.3 | 2.6 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.3 | 2.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 4.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 0.9 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.3 | 1.7 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.3 | 0.9 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.3 | 2.5 | GO:0061574 | ASAP complex(GO:0061574) |
0.3 | 10.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.3 | 1.7 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.3 | 3.0 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.3 | 0.8 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.3 | 2.2 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.3 | 3.5 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.3 | 1.6 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.3 | 1.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.3 | 2.9 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.3 | 1.3 | GO:0097361 | CIA complex(GO:0097361) |
0.3 | 0.8 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.3 | 1.3 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 20.2 | GO:0005814 | centriole(GO:0005814) |
0.2 | 2.0 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 1.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 3.7 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 0.7 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.2 | 1.0 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 2.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 27.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 2.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 2.4 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 3.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.2 | 0.2 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) |
0.2 | 5.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 0.9 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 4.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 14.5 | GO:0000776 | kinetochore(GO:0000776) |
0.2 | 1.3 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.2 | 1.9 | GO:0030686 | 90S preribosome(GO:0030686) |
0.2 | 0.6 | GO:0098835 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
0.2 | 1.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 2.3 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.2 | 4.4 | GO:0001741 | XY body(GO:0001741) |
0.2 | 0.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 2.4 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 0.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 1.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 0.8 | GO:0090537 | CERF complex(GO:0090537) |
0.2 | 3.1 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 2.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 3.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.8 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.2 | 3.7 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 2.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 0.9 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.2 | 0.9 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 2.2 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.2 | 1.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.2 | 0.9 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 2.7 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.2 | 0.7 | GO:0071953 | elastic fiber(GO:0071953) |
0.2 | 1.0 | GO:0051286 | cell tip(GO:0051286) |
0.2 | 1.3 | GO:0097346 | INO80-type complex(GO:0097346) |
0.2 | 1.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 1.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.2 | 3.4 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 1.6 | GO:0036038 | MKS complex(GO:0036038) |
0.2 | 8.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.2 | 1.2 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 1.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 2.0 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 0.8 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 2.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 4.5 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 0.6 | GO:0035838 | growing cell tip(GO:0035838) new growing cell tip(GO:0035841) |
0.1 | 0.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.6 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.1 | 0.6 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 8.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 5.4 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.3 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 5.6 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 0.8 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 1.8 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 1.3 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 1.2 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.3 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 4.6 | GO:0043034 | costamere(GO:0043034) |
0.1 | 42.2 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.5 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 2.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.4 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 0.4 | GO:0044753 | amphisome(GO:0044753) |
0.1 | 0.7 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.5 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.1 | 1.3 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 6.0 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.1 | 1.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.3 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
0.1 | 1.1 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.6 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.1 | 0.7 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.3 | GO:1990752 | microtubule end(GO:1990752) |
0.1 | 0.2 | GO:0031310 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
0.1 | 2.0 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 1.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 1.0 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 2.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 3.5 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 1.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 1.2 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 1.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.1 | 0.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 0.5 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 3.5 | GO:0031672 | A band(GO:0031672) |
0.1 | 4.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 1.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 5.2 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 2.8 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.4 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 1.0 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.6 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 7.1 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 0.2 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.1 | 1.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.3 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.1 | 3.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 1.0 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.1 | 12.3 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 0.6 | GO:0061702 | inflammasome complex(GO:0061702) |
0.1 | 0.9 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 0.8 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.3 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.1 | 2.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.1 | GO:0034774 | secretory granule lumen(GO:0034774) cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
0.1 | 0.3 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.1 | 0.7 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 2.4 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 0.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 1.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 1.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 4.9 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 2.1 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 0.8 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 0.2 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 2.8 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 3.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.8 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 0.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.1 | 0.7 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 1.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.4 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 11.9 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.3 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 1.0 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.4 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 5.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 1.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.0 | 1.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.3 | GO:0090544 | BAF-type complex(GO:0090544) |
0.0 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 5.4 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.1 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.0 | 0.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 0.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.1 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.0 | 1.8 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.0 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 4.3 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 1.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.0 | 0.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.0 | 0.1 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.0 | 0.0 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 11.5 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
3.3 | 13.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
2.8 | 27.8 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.5 | 7.6 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
2.3 | 14.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
2.2 | 6.6 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
2.1 | 8.6 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
2.1 | 14.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.9 | 7.7 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
1.9 | 5.7 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
1.9 | 11.3 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
1.8 | 5.5 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
1.8 | 16.4 | GO:1990446 | U1 snRNP binding(GO:1990446) |
1.8 | 5.4 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
1.8 | 9.0 | GO:0030621 | U4 snRNA binding(GO:0030621) |
1.8 | 1.8 | GO:0070990 | snRNP binding(GO:0070990) |
1.7 | 5.0 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) interleukin-1 Type I receptor antagonist activity(GO:0045352) interleukin-1 Type II receptor antagonist activity(GO:0045353) |
1.7 | 23.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
1.6 | 1.6 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
1.6 | 12.8 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
1.6 | 6.3 | GO:0000010 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
1.6 | 6.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.4 | 18.8 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
1.4 | 11.6 | GO:0050786 | RAGE receptor binding(GO:0050786) |
1.4 | 6.9 | GO:0043515 | kinetochore binding(GO:0043515) |
1.4 | 14.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
1.3 | 12.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.3 | 8.0 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.3 | 6.3 | GO:0042610 | CD8 receptor binding(GO:0042610) |
1.2 | 3.7 | GO:0070138 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
1.2 | 4.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.2 | 3.6 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
1.2 | 3.5 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
1.2 | 11.6 | GO:0051434 | BH3 domain binding(GO:0051434) |
1.2 | 3.5 | GO:0034188 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
1.2 | 5.8 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
1.1 | 5.6 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
1.1 | 10.1 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
1.1 | 3.3 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
1.1 | 8.7 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.1 | 11.7 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
1.1 | 3.2 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
1.0 | 12.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
1.0 | 6.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
1.0 | 5.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.0 | 8.9 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.0 | 4.9 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
1.0 | 2.9 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
1.0 | 5.7 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.9 | 3.7 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.9 | 3.7 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.9 | 4.5 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.9 | 0.9 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.9 | 2.7 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.9 | 2.7 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
0.9 | 8.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.8 | 2.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.8 | 1.7 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.8 | 2.5 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.8 | 4.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.8 | 17.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.8 | 8.8 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.8 | 2.4 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.8 | 2.3 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.7 | 2.9 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.7 | 6.4 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.7 | 0.7 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.7 | 3.5 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.7 | 2.8 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
0.7 | 13.2 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.7 | 6.9 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.7 | 5.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.7 | 2.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.7 | 2.0 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
0.7 | 11.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.7 | 5.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.7 | 2.7 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.7 | 5.3 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.7 | 5.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.7 | 5.9 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.7 | 7.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.6 | 1.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.6 | 1.9 | GO:0098809 | nitrite reductase activity(GO:0098809) |
0.6 | 3.2 | GO:0043532 | angiostatin binding(GO:0043532) |
0.6 | 14.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.6 | 2.6 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.6 | 3.8 | GO:0042731 | PH domain binding(GO:0042731) |
0.6 | 31.0 | GO:0019843 | rRNA binding(GO:0019843) |
0.6 | 15.8 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.6 | 6.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.6 | 2.5 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.6 | 0.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.6 | 1.9 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.6 | 1.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.6 | 3.1 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.6 | 2.5 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.6 | 2.4 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.6 | 0.6 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
0.6 | 1.8 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
0.6 | 4.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.6 | 4.7 | GO:0004064 | arylesterase activity(GO:0004064) |
0.6 | 2.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.6 | 4.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.6 | 4.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.6 | 2.9 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.6 | 1.7 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.6 | 2.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.6 | 3.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.6 | 3.9 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.5 | 1.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.5 | 1.1 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.5 | 2.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.5 | 2.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.5 | 1.6 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.5 | 7.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.5 | 9.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.5 | 6.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.5 | 74.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.5 | 17.4 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.5 | 1.5 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.5 | 7.6 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.5 | 2.5 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.5 | 1.0 | GO:0036004 | GAF domain binding(GO:0036004) |
0.5 | 1.5 | GO:0009918 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
0.5 | 9.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.5 | 1.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.5 | 1.9 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.5 | 2.3 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.5 | 3.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.5 | 1.4 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.5 | 1.8 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.5 | 5.4 | GO:0005522 | profilin binding(GO:0005522) |
0.5 | 1.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.4 | 1.3 | GO:0070737 | protein-glycine ligase activity, elongating(GO:0070737) |
0.4 | 30.7 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.4 | 3.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.4 | 3.5 | GO:0030911 | TPR domain binding(GO:0030911) |
0.4 | 1.7 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.4 | 7.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.4 | 0.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.4 | 1.3 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.4 | 1.7 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.4 | 2.1 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.4 | 6.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.4 | 1.3 | GO:0004686 | elongation factor-2 kinase activity(GO:0004686) |
0.4 | 2.9 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.4 | 0.8 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.4 | 1.2 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
0.4 | 2.0 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.4 | 5.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.4 | 2.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.4 | 10.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.4 | 3.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.4 | 1.9 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.4 | 1.9 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.4 | 1.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 2.7 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.4 | 0.8 | GO:0035173 | histone kinase activity(GO:0035173) |
0.4 | 11.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.4 | 1.1 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.4 | 1.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.4 | 1.1 | GO:0019202 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
0.4 | 2.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.4 | 18.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.4 | 1.1 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.3 | 2.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.3 | 3.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.3 | 0.7 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.3 | 1.0 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
0.3 | 6.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.3 | 3.7 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.3 | 1.3 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.3 | 13.3 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.3 | 1.3 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.3 | 1.0 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.3 | 20.0 | GO:0004601 | peroxidase activity(GO:0004601) |
0.3 | 1.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 15.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.3 | 0.6 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.3 | 3.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.3 | 0.3 | GO:0032356 | oxidized DNA binding(GO:0032356) |
0.3 | 0.9 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 0.9 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.3 | 1.2 | GO:0004488 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.3 | 10.5 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.3 | 1.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 0.9 | GO:0019956 | chemokine binding(GO:0019956) |
0.3 | 0.9 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.3 | 2.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.3 | 1.8 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.3 | 0.9 | GO:0008494 | translation activator activity(GO:0008494) |
0.3 | 6.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.3 | 0.9 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
0.3 | 2.0 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.3 | 9.0 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 11.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 1.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.3 | 2.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 0.8 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
0.3 | 0.5 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.3 | 1.4 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.3 | 1.1 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
0.3 | 16.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.3 | 9.1 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.3 | 0.8 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.3 | 1.3 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.3 | 1.3 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.3 | 1.0 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.3 | 0.8 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.3 | 1.5 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.3 | 0.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.3 | 0.3 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.3 | 1.5 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.3 | 16.8 | GO:0008186 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.3 | 6.5 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.2 | 2.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 11.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 2.0 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.2 | 16.6 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 2.7 | GO:0015266 | protein channel activity(GO:0015266) |
0.2 | 0.5 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.2 | 1.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 0.5 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.2 | 1.7 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.2 | 0.7 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.2 | 2.8 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.2 | 7.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.2 | 2.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 0.7 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 4.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 0.7 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 5.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.2 | 1.4 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.2 | 0.2 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
0.2 | 0.7 | GO:0004482 | mRNA (guanine-N7-)-methyltransferase activity(GO:0004482) |
0.2 | 0.7 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.2 | 1.1 | GO:0034618 | arginine binding(GO:0034618) |
0.2 | 1.4 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.2 | 0.5 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 1.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 3.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 0.9 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.2 | 0.4 | GO:0048030 | disaccharide binding(GO:0048030) |
0.2 | 4.2 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 7.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 4.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 0.7 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.2 | 0.9 | GO:2001069 | glycogen binding(GO:2001069) |
0.2 | 12.7 | GO:0035064 | methylated histone binding(GO:0035064) |
0.2 | 1.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 1.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 0.9 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 0.6 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.2 | 1.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 1.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 4.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 2.7 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 0.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 1.3 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.2 | 11.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 0.6 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.2 | 18.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.2 | 1.0 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.2 | 1.0 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.2 | 0.8 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.2 | 4.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 6.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 9.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 1.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 1.0 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.2 | 1.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.2 | 1.6 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.2 | 1.6 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.2 | 2.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.2 | 2.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 1.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 7.0 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.2 | 2.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 1.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 0.9 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.2 | 3.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 1.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.2 | 0.7 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.2 | 0.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.2 | 0.7 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.2 | 0.5 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.2 | 0.7 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.2 | 0.4 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
0.2 | 0.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.2 | 4.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 21.2 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 0.2 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.2 | 1.4 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 2.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.9 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 1.2 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 3.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.2 | 1.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 2.0 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.2 | 0.8 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.2 | 3.4 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.2 | 0.7 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 0.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 1.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 1.9 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.2 | 0.6 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.2 | 0.5 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.2 | 2.5 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 9.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 1.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 0.8 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
0.2 | 2.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 0.9 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.2 | 0.6 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 6.8 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 0.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 2.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 0.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 0.6 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.4 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.1 | 0.3 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.1 | 0.6 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 5.1 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.1 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.1 | 0.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.9 | GO:0008486 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.1 | 0.4 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.9 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 1.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.8 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 3.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 1.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 1.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.6 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.1 | 8.5 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 0.8 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.1 | 0.4 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.1 | 0.1 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.1 | 0.5 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.1 | 1.9 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 0.5 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 0.9 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 0.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 2.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.1 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.1 | 0.5 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.1 | 21.0 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.1 | 0.8 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.4 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.1 | 0.1 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.1 | 0.5 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.1 | 0.4 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
0.1 | 0.4 | GO:0031208 | POZ domain binding(GO:0031208) |
0.1 | 0.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.5 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.1 | 1.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.4 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.4 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 1.8 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.2 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.1 | 3.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.6 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 0.6 | GO:1990188 | euchromatin binding(GO:1990188) |
0.1 | 1.8 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.1 | 0.6 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 1.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.2 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
0.1 | 1.4 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.1 | 2.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 1.0 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.1 | 2.6 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 1.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 5.6 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.1 | 0.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 2.4 | GO:0019239 | deaminase activity(GO:0019239) |
0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 2.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 2.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 4.0 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.4 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 4.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 2.0 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.1 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
0.1 | 0.2 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.1 | 0.3 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 0.3 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 0.9 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 2.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 6.4 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.5 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 1.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.5 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 0.4 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.1 | 1.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.6 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 16.0 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.1 | 0.4 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.3 | GO:0050436 | microfibril binding(GO:0050436) |
0.1 | 1.0 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 1.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 5.0 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 2.4 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.2 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.1 | 2.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 3.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.2 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.1 | 0.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 1.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.9 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.2 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 0.2 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.1 | 0.3 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.1 | 0.3 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.1 | GO:0070976 | TIR domain binding(GO:0070976) |
0.1 | 0.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.1 | 0.9 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.6 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.1 | 0.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.4 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
0.1 | 0.4 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 22.1 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 1.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.6 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.1 | GO:0051431 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 1.6 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 1.0 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.2 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 1.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.5 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 0.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 3.5 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 2.9 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.6 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 9.3 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 0.3 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.1 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.4 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 2.8 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 1.6 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 1.1 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 2.5 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 1.1 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.1 | 0.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.2 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 1.6 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.1 | 0.3 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.3 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.6 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 7.1 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 0.3 | GO:0015265 | urea channel activity(GO:0015265) |
0.1 | 2.3 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 52.9 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 0.4 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 0.7 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.1 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.1 | 5.5 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.4 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 1.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.1 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.0 | 0.0 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.0 | 0.3 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.0 | 3.6 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.2 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.0 | 0.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.2 | GO:0045182 | translation regulator activity(GO:0045182) |
0.0 | 1.1 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 1.5 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.1 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
0.0 | 1.3 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 1.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.0 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.5 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 0.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.1 | GO:0047874 | dolichyldiphosphatase activity(GO:0047874) |
0.0 | 0.1 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.0 | 0.5 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.2 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.0 | 0.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 1.3 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.2 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.0 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.5 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.4 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 4.0 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.0 | 0.2 | GO:1901612 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.0 | 0.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.1 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.0 | 0.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.7 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.0 | 0.1 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.0 | 0.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 8.0 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 0.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.0 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 0.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.0 | 0.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.1 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.0 | 1.1 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.1 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.0 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 25.9 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
1.0 | 41.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.9 | 37.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.9 | 42.1 | PID ATR PATHWAY | ATR signaling pathway |
0.7 | 5.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.6 | 12.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.6 | 9.3 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.6 | 28.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.6 | 6.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.5 | 21.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.5 | 18.3 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.5 | 0.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.5 | 16.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.5 | 9.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.5 | 14.6 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.5 | 0.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.4 | 11.2 | PID MYC PATHWAY | C-MYC pathway |
0.4 | 16.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.4 | 7.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.4 | 5.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.4 | 0.4 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.4 | 0.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.4 | 0.7 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.3 | 13.3 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.3 | 12.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.3 | 4.2 | PID EPO PATHWAY | EPO signaling pathway |
0.3 | 5.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.3 | 1.8 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 6.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 1.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.3 | 7.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 21.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 9.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 0.3 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.3 | 6.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 6.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.2 | 1.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 1.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 2.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.2 | 16.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 16.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 8.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 6.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.2 | 10.9 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 6.2 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 0.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 1.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 5.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 3.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 4.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 5.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 5.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 9.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 6.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 4.9 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 1.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 3.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 3.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 5.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 6.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 2.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 3.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 5.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 1.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 5.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 4.9 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 3.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 2.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.4 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 14.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.3 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 3.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 10.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 3.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 1.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 1.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 2.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 3.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 0.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 4.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 2.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 4.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 1.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 1.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 1.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 0.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 1.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 1.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.6 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.2 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 34.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
1.7 | 13.6 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
1.6 | 19.7 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
1.2 | 31.9 | REACTOME KINESINS | Genes involved in Kinesins |
1.2 | 63.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
1.1 | 22.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
1.1 | 12.0 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
1.1 | 76.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
1.0 | 19.0 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
1.0 | 1.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.9 | 3.8 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.8 | 18.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.8 | 11.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.8 | 2.3 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
0.7 | 32.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.7 | 4.2 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.7 | 0.7 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.7 | 5.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.6 | 9.5 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.6 | 12.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.6 | 17.7 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.6 | 6.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.6 | 10.6 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.6 | 25.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.6 | 59.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.6 | 8.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.6 | 11.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.6 | 5.6 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.6 | 6.6 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
0.6 | 8.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.5 | 10.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.5 | 12.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.5 | 7.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.5 | 5.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.5 | 2.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.5 | 7.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.5 | 13.6 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.5 | 9.6 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.5 | 25.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.5 | 7.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.5 | 6.7 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.5 | 7.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.5 | 0.9 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.4 | 7.9 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.4 | 7.8 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.4 | 11.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.4 | 4.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.4 | 0.8 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.4 | 12.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.4 | 4.1 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.4 | 9.6 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.4 | 0.8 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.4 | 10.9 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.4 | 7.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.4 | 4.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.3 | 2.4 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.3 | 2.7 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.3 | 5.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.3 | 11.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 3.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.3 | 4.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 1.9 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.3 | 5.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 8.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.3 | 4.2 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.3 | 8.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.3 | 6.5 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.3 | 0.6 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.3 | 1.2 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.3 | 14.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.3 | 3.0 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.3 | 13.6 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.2 | 13.3 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 0.2 | REACTOME S PHASE | Genes involved in S Phase |
0.2 | 5.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 1.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 2.9 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.2 | 1.3 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 8.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 9.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 4.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 12.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 4.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 9.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 0.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 5.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 1.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 4.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 2.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 4.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.2 | 2.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 0.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 3.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 2.0 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 0.9 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 28.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 3.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 1.3 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 12.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 5.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 0.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.5 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 1.4 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 4.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 1.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 2.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.7 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 12.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 2.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 1.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 2.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.3 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 1.4 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 1.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 4.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 0.6 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 1.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 4.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 3.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 1.0 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 1.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 7.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 0.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 0.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 2.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 3.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 1.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 3.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.7 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 0.4 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.1 | 0.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.5 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.1 | 1.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.2 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 2.2 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 3.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 1.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.7 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 0.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 1.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 2.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.3 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 1.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.8 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 1.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 1.6 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.9 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 0.4 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.8 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 1.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 1.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.4 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.0 | 0.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.5 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 2.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.4 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.0 | 0.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.1 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.0 | 0.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.5 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.0 | 0.1 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |